Insights

Functional near-infrared spectroscopy (fNIRS) can distinguish mild cognitive impairment (MCI) patients from healthy individuals during memory tasks. This neuroimaging technique shows potential as a diagnostic tool for early-stage Alzheimer's disease detection.

Area of Science:

  • Neuroscience
  • Medical Imaging
  • Cognitive Science

Background:

  • Early diagnosis of dementia is crucial for managing cognitive decline in aging populations.
  • Mild cognitive impairment (MCI) represents an early stage of Alzheimer's disease (AD).
  • Distinguishing MCI from healthy aging is essential for timely intervention.

Purpose of the Study:

  • To classify individuals with MCI from healthy controls (HC) using functional near-infrared spectroscopy (fNIRS).
  • To investigate the utility of fNIRS during working memory tasks for MCI detection.
  • To identify brain activity patterns indicative of MCI.

Main Methods:

  • fNIRS data were collected during working memory tasks.
  • Region of Interest (ROI) channels and brain connectivity were identified using t-values and correlation coefficients.
  • Hemodynamic response (HR) features (mean and slope) were extracted from ROI channels.
  • Linear Discriminant Analysis (LDA) and Support Vector Machine (SVM) were employed for classification.

Main Results:

  • Classification accuracy reached 73.08% with LDA and 71.15% with SVM.
  • Significant differences in hemodynamic responses (HR) were observed between MCI patients and HC.
  • fNIRS successfully differentiated between the two groups based on brain activity patterns.

Conclusions:

  • fNIRS shows promise as a non-invasive diagnostic tool for identifying MCI.
  • The study highlights the potential of neuroimaging in early AD detection.
  • Hemodynamic responses during working memory tasks are valuable biomarkers for MCI.